Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Dec 30, 2021

Dr. Dan Gold is the President and CEO of MEI Pharma and is tackling non-Hodgkin's B cell lymphoma to bring a therapy to patients minimizing the toxicities that are associated with current treatments. Their drug candidate zandelisib is a P13K delta inhibitor. It is being studied in lymphoma in B cells to determine if...


Dec 30, 2021

Dr. Dan Gold is the President and CEO of MEI Pharma and is tackling non-Hodgkin's B cell lymphoma to bring a therapy to patients minimizing the toxicities that are associated with current treatments. Their drug candidate zandelisib is a P13K delta inhibitor. It is being studied in lymphoma in B cells to determine if...


Dec 29, 2021

Justin Miller is the VP of Customer Success at eVisit and has recently returned from a tour of client sites to see how telehealth is functioning particularly in the real-world application of the Emergency Triage, Treat, and Transport (ET3) emergency medical response model. eVisit is the only end-to-end enterprise care...


Dec 29, 2021

Justin Miller is the VP of Customer Success at eVisit and has recently returned from a tour of client sites to see how telehealth is functioning particularly in the real-world application of the Emergency Triage, Treat, and Transport (ET3) emergency medical response model. eVisit is the only end-to-end enterprise care...


Dec 28, 2021

Bill Hinshaw is the President and CEO of Axcella Therapeutics, a clinical-stage biotech company founded by Flagship Pioneering, Founder of Moderna. Using their platform to create compositions of endogenous metabolic modulators, EMMs, Axcella has generated two liver programs including 1125 for treating NASH.  Preclinical...